Akero Therapeutics, Inc. Stock-Based Compensation
Akero Therapeutics, Inc. reported Stock-Based Compensation of $27.10 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-11-07
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $9.26M, a 24.01% increase year-over-year.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $9.05M, a 18.27% increase year-over-year.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $8.78M, a 18.73% increase year-over-year.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $7.18M, a 17.33% increase year-over-year.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $29.70M, a 38.15% increase from fiscal 2023.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $21.50M, a 7.51% decline from fiscal 2022.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $23.24M, a 131.18% increase from fiscal 2021.
- Akero Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $10.05M, a 66.95% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-09-30 | $9.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $18.32M derived: sum of 2 quarters · filed 2025-11-07 | $27.10M 10-Q · filed 2025-11-07 | $34.28M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | $9.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $17.84M 10-Q · filed 2025-08-08 | $25.02M derived: sum of 3 quarters · filed 2025-08-08 | $32.48M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | $8.78M 10-Q · filed 2025-05-12 | $15.96M derived: sum of 2 quarters · filed 2025-05-12 | $23.43M derived: sum of 3 quarters · filed 2025-11-07 | $31.08M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | $7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $14.64M derived: sum of 2 quarters · filed 2025-11-07 | $22.30M derived: sum of 3 quarters · filed 2025-11-07 | $29.70M 10-K · filed 2025-02-28 |
| 2024-09-30 | $7.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $15.12M derived: sum of 2 quarters · filed 2025-11-07 | $22.52M 10-Q · filed 2025-11-07 | $28.64M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $15.05M 10-Q · filed 2025-08-08 | $21.17M derived: sum of 3 quarters · filed 2025-08-08 | $26.91M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $7.40M 10-Q · filed 2025-05-12 | $13.51M derived: sum of 2 quarters · filed 2025-05-12 | $19.25M derived: sum of 3 quarters · filed 2025-05-12 | $24.05M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $11.86M derived: sum of 2 quarters · filed 2025-02-28 | $16.65M derived: sum of 3 quarters · filed 2025-02-28 | $21.50M 10-K · filed 2025-02-28 |
| 2023-09-30 | $5.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $10.54M derived: sum of 2 quarters · filed 2024-11-08 | $15.38M 10-Q · filed 2024-11-08 | $19.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $9.64M 10-Q · filed 2024-08-09 | $13.68M derived: sum of 3 quarters · filed 2025-02-28 | $25.41M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $4.84M 10-Q · filed 2024-05-10 | $8.88M derived: sum of 2 quarters · filed 2025-02-28 | $20.61M derived: sum of 3 quarters · filed 2025-02-28 | $24.78M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $15.77M derived: sum of 2 quarters · filed 2025-02-28 | $19.93M derived: sum of 3 quarters · filed 2025-02-28 | $23.24M 10-K · filed 2025-02-28 |
| 2022-09-30 | $11.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $15.89M derived: sum of 2 quarters · filed 2023-11-13 | $19.20M 10-Q · filed 2023-11-13 | $21.84M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $7.47M 10-Q · filed 2023-08-11 | $10.11M derived: sum of 3 quarters · filed 2024-02-29 | $12.73M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $3.31M 10-Q · filed 2023-05-15 | $5.95M derived: sum of 2 quarters · filed 2024-02-29 | $8.56M derived: sum of 3 quarters · filed 2024-02-29 | $11.00M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $5.25M derived: sum of 2 quarters · filed 2024-02-29 | $7.69M derived: sum of 3 quarters · filed 2024-02-29 | $10.05M 10-K · filed 2024-02-29 |
| 2021-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $5.05M derived: sum of 2 quarters · filed 2022-11-04 | $7.41M 10-Q · filed 2022-11-04 | $9.33M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.80M 10-Q · filed 2022-08-05 | $6.72M derived: sum of 3 quarters · filed 2022-08-05 | $8.26M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $2.36M 10-Q · filed 2022-05-06 | $4.28M derived: sum of 2 quarters · filed 2022-05-06 | $5.83M derived: sum of 3 quarters · filed 2022-05-06 | $7.15M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.46M derived: sum of 2 quarters · filed 2022-02-25 | $4.79M derived: sum of 3 quarters · filed 2022-02-25 | $6.02M 10-K · filed 2022-02-25 |
| 2020-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.87M derived: sum of 2 quarters · filed 2021-11-12 | $4.11M 10-Q · filed 2021-11-12 | $4.78M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.56M 10-Q · filed 2021-08-13 | $3.23M derived: sum of 3 quarters · filed 2022-02-25 | $3.71M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $1.24M 10-Q · filed 2021-05-13 | $1.91M derived: sum of 2 quarters · filed 2022-02-25 | $2.39M derived: sum of 3 quarters · filed 2022-02-25 | $2.79M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.15M derived: sum of 2 quarters · filed 2022-02-25 | $1.55M derived: sum of 3 quarters · filed 2022-02-25 | $1.77M 10-K · filed 2022-02-25 |
| 2019-09-30 | $483.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $885.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.10M 10-Q · filed 2020-11-12 | $1.19M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $402.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $617.00K 10-Q · filed 2020-08-12 | $704.00K derived: sum of 3 quarters · filed 2020-08-12 | |
| 2019-03-31 | $215.00K 10-Q · filed 2020-05-13 | $302.00K derived: sum of 2 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $121.00K 10-K · filed 2020-03-16 | ||
| 2018-09-30 | $34.00K 10-Q · filed 2019-11-12 |